Banking, Finance, Insurance and Securities (BFIS) Consultancy - Financial Healthcare and Medicine

United States Senate Tender

📄 Tender ID: 443368613 📅 Published: 05 Apr 2019

📋 Tender Overview

Last night the Senate passed U.S. Senator Sherrod Browns D-OH bipartisan measure to prevent drug companies from misclassifying their medications as generic drugs to charge Medicaid and therefore taxpayers more money. Browns measure follows Mylans 465 million settlement with the U.S. Department of Justice DOJ for overcharging Medicaid by millions of dollars by misclassifying their EpiPen as a generic medication. Browns bill would give the U.S. Department of Health and Human Services HHS the ability to correctly reclassify a medication and recoup any rebates given to the drug companies when they misclassify a drug. Browns measure is part of a bipartisan bill that now heads to the Presidents desk to be signed into law. Taxpayers should not be on the hook for the drug companies corporate greed said Brown. By going after bad actors who try to rig the game in their favor by misclassifying their products we can cut down on costs and protect Ohio taxpayers who rely on these medications for their health and the health of their families.

🔍 Key Information

📄
Tender Reference No.
443368613
📅
Publication Date
05 Apr 2019
🌐
Sector
Banking, Finance, Insurance and Securities (BFIS)
📝
Notice Type
News
📍
Location
United states

📁 Documents & Downloads

No documents found

🏷️ CPV

No CPV found

Need help with this bid?

Our bid experts can help you find, evaluate & win more tenders.

🎧 Talk to Bid Expert
🕒 Submission deadline
0
days remaining · 05 Apr 2019
🔔 Set Alert

🧭 Quick Facts

Authority N/A
Country United states
State / UT N/A
Tender Type Procurement News
Currency N/A
Similar Tenders
Loading similar tenders…